OBJECTIVE: To evaluate the effectiveness and safety of 3 predominant venous thromboembolism (VTE) prophylaxis strategies among patients undergoing bariatric surgery. DESIGN: Cohort study. SETTING: The Michigan Bariatric Surgery Collaborative, a statewide clinical registry and quality improvement program. PATIENTS: Twenty-four thousand seven hundred seventy-seven patients undergoing bariatric surgery between 2007 and 2012. INTERVENTIONS: Unfractionated heparin preoperatively and postoperatively (UF/UF), UF heparin preoperatively and low-molecular-weight heparin postoperatively (UF/LMW), and LMW heparin preoperatively and postoperatively (LMW/LMW). MAIN OUTCOME MEASURES: Rates of VTE, hemorrhage, and serious hemorrhage (requiring >4 U of blood products or reoperation) occurring within 30 days of surgery. RESULTS: Overall, adjusted rates of VTE were significantly lower for the LMW/LMW (0.25%; P < .001) and UF/LMW (0.29%; P = .03) treatment groups compared with the UF/UF group (0.68%). While UF/LMW (0.22%; P = .006) and LMW/LMW (0.21%; P < .001) were similarly effective in patients at low risk of VTE (predicted risk <1%), LMW/LMW (1.46%; P = .10) seemed more effective than UF/LMW (2.36%; P = .90) for high-risk (predicted risk ≥1%) patients. There were no significant differences in rates of hemorrhage or serious hemorrhage among the treatment strategies. CONCLUSION: Low-molecular-weight heparin is more effective than UF heparin for the prevention of postoperative VTE among patients undergoing bariatric surgery and does not increase rates of bleeding.
OBJECTIVE: To evaluate the effectiveness and safety of 3 predominant venous thromboembolism (VTE) prophylaxis strategies among patients undergoing bariatric surgery. DESIGN: Cohort study. SETTING: The Michigan Bariatric Surgery Collaborative, a statewide clinical registry and quality improvement program. PATIENTS: Twenty-four thousand seven hundred seventy-seven patients undergoing bariatric surgery between 2007 and 2012. INTERVENTIONS: Unfractionated heparin preoperatively and postoperatively (UF/UF), UF heparin preoperatively and low-molecular-weight heparin postoperatively (UF/LMW), and LMW heparin preoperatively and postoperatively (LMW/LMW). MAIN OUTCOME MEASURES: Rates of VTE, hemorrhage, and serious hemorrhage (requiring >4 U of blood products or reoperation) occurring within 30 days of surgery. RESULTS: Overall, adjusted rates of VTE were significantly lower for the LMW/LMW (0.25%; P < .001) and UF/LMW (0.29%; P = .03) treatment groups compared with the UF/UF group (0.68%). While UF/LMW (0.22%; P = .006) and LMW/LMW (0.21%; P < .001) were similarly effective in patients at low risk of VTE (predicted risk <1%), LMW/LMW (1.46%; P = .10) seemed more effective than UF/LMW (2.36%; P = .90) for high-risk (predicted risk ≥1%) patients. There were no significant differences in rates of hemorrhage or serious hemorrhage among the treatment strategies. CONCLUSION: Low-molecular-weight heparin is more effective than UF heparin for the prevention of postoperative VTE among patients undergoing bariatric surgery and does not increase rates of bleeding.
Authors: Jerry T Dang; Vivian G Szeto; Ahmad Elnahas; James Ellsmere; Allan Okrainec; Amy Neville; Samaad Malik; Ekua Yorke; Dennis Hong; Laurent Biertho; Timothy Jackson; Shahzeer Karmali Journal: Surg Endosc Date: 2019-06-17 Impact factor: 4.584
Authors: Mohammad H Jamal; Ricard Corcelles; Hideharu Shimizu; Mathew Kroh; Fernando M Safdie; Raul Rosenthal; Stacy A Brethauer; Philip R Schauer Journal: Surg Endosc Date: 2014-07-02 Impact factor: 4.584
Authors: Robert W Krell; Nancy J O Birkmeyer; Bradley N Reames; Arthur M Carlin; John D Birkmeyer; Jonathan F Finks Journal: J Am Coll Surg Date: 2013-10-29 Impact factor: 6.113
Authors: Vahagn C Nikolian; Neil S Kamdar; Scott E Regenbogen; Arden M Morris; John C Byrn; Pasithorn A Suwanabol; Darrell A Campbell; Samantha Hendren Journal: Surgery Date: 2017-02-21 Impact factor: 3.982
Authors: Maria S Altieri; Jie Yang; Janos Hajagos; Konstantinos Spaniolas; Jihye Park; Antonios P Gasparis; Andrew T Bates; Salvatore Docimo; Mark Talamini; A Laurie Shroyer; Aurora D Pryor Journal: Surg Endosc Date: 2018-05-15 Impact factor: 4.584